Atlas Trials

Dabigatran Versus Conventional Treatment for Prevention of Silent Cerebral Infarct in Atrial Fibrillation Associated With Valvular Disease

Clinical trial NCT02982850 · COMPLETED

Trial details

NCT number
NCT02982850
Sponsor
Asan Medical Center
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Atrial FibrillationValve Heart Disease
Start date
2016-12-01
Primary completion
2020-10-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.